Evidence map›Paper›PMID 37995110›Full record

ArticleJournal of medical Internet research2023

Identification of Key Influencers for Secondary Distribution of HIV Self-Testing Kits Among Chinese Men Who Have Sex With Men: Development of an Ensemble Machine Learning Approach.

Fengshi Jing, Yang Ye, Yi Zhou, Yuxin Ni, Xumeng Yan, Ying Lu, Jason Ong, Joseph D Tucker, Dan Wu, Yuan Xiong and 12 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Fengshi Jing *Institute for Healthcare Artificial Intelligence Application, Guangdong Second Provincial General Hospital, Guangzhou, China.ORCID 0000-0002-6747-6527
Yang Ye *School of Data Science, City University of Hong Kong, Hong Kong Special Administrative Region, China.ORCID 0000-0003-0710-1341
Yi Zhou *Department of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0000-0001-6560-1059
Yuxin NiUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-0580-6946
Xumeng YanUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0001-6677-2490
Ying LuUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-5057-1763
Jason OngLondon School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-5784-7403
Joseph D TuckerUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-2804-1181
Dan WuUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-0415-5467
Yuan XiongUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-3461-8688
Chen XuUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-1768-3624
Xi HeZhuhai Xutong Voluntary Services Center, Zhuhai, China.ORCID 0000-0003-0541-9962
Shanzi HuangDepartment of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0000-0001-7857-4053
Xiaofeng LiDepartment of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0000-0001-7141-8779
Hongbo JiangDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China.ORCID 0000-0002-0631-4460
Cheng WangDermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0001-8000-9969
Wencan DaiDepartment of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0000-0002-2012-3214
Liqun HuangDepartment of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0009-0004-3133-3657
Wenhua MeiDepartment of HIV Prevention, Zhuhai Center for Diseases Control and Prevention, Zhuhai, China.ORCID 0009-0008-5330-3570
Weibin ChengInstitute for Healthcare Artificial Intelligence Application, Guangdong Second Provincial General Hospital, Guangzhou, China.ORCID 0000-0002-9845-6676
Qingpeng Zhang *Institute of Data Science and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administrative Region, China.ORCID 0000-0002-6819-0686
Weiming Tang *Institute for Healthcare Artificial Intelligence Application, Guangdong Second Provincial General Hospital, Guangzhou, China.ORCID 0000-0002-9026-707X

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Mentoring Multidisciplinary Global HIV Patient-Oriented ResearchK24AI143471 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph David Tucker · 2019 to 2026
$1.4M
Enhancing Partner Services among Men Who Have Sex with Men Living With HIV: A Pilot Randomized Controlled TrialR34MH119963 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2019 to 2021
$568k
NIAID NIH HHS K24 AI143471NIAID NIH HHS P30 AI050410NIMH NIH HHS R34 MH119963
6 · The paper itself

Abstract

backgroundHIV self-testing (HIVST) has been rapidly scaled up and additional strategies further expand testing uptake. Secondary distribution involves people (defined as "indexes") applying for multiple kits and subsequently sharing them with people (defined as "alters") in their social networks. However, identifying key influencers is difficult.

objectiveThis study aimed to develop an innovative ensemble machine learning approach to identify key influencers among Chinese men who have sex with men (MSM) for secondary distribution of HIVST kits.

methodsWe defined three types of key influencers: (1) key distributors who can distribute more kits, (2) key promoters who can contribute to finding first-time testing alters, and (3) key detectors who can help to find positive alters. Four machine learning models (logistic regression, support vector machine, decision tree, and random forest) were trained to identify key influencers. An ensemble learning algorithm was adopted to combine these 4 models. For comparison with our machine learning models, self-evaluated leadership scales were used as the human identification approach. Four metrics for performance evaluation, including accuracy, precision, recall, and F

resultsWe included 309 indexes (our sample size) who were eligible and applied for multiple test kits; they distributed these kits to 269 alters. We compared the performance of the machine learning classification and ensemble learning models with that of the human identification approach based on leadership self-evaluated scales in terms of the 2 nearest cutoffs. Our approach outperformed human identification (based on the cutoff of the self-reported scales), exceeding by an average accuracy of 11.0%, could distribute 18.2% (95% CI 9.9%-26.5%) more kits, and find 13.6% (95% CI 1.9%-25.3%) more first-time testing alters and 12.0% (95% CI -14.7% to 38.7%) more positive-testing alters. Our approach could also increase the simulated intervention's efficiency by 17.7% (95% CI -3.5% to 38.8%) compared to that of human identification.

conclusionsWe built machine learning models to identify key influencers among Chinese MSM who were more likely to engage in secondary distribution of HIVST kits.

trial registrationChinese Clinical Trial Registry (ChiCTR) ChiCTR1900025433; https://www.chictr.org.cn/showproj.html?proj=42001.

Indexed as

HIV InfectionsSexual and Gender MinoritiesEast Asian PeopleHomosexuality, MaleHumansMaleReagent Kits, DiagnosticSelf CareSelf-TestingReagent Kits, DiagnosticHIV self-testingkey influencers identificationmachine learningmen who have sex with menMSMsecondary distribution

Identifiers

PMID37995110
PMCPMC10704319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.